ARTICLE SUMMARY:
With a novel auto-injection technology, Oval Medical improves upon first generation products like EpiPen for the intramuscular injection of drugs, and prepares for the growth of the biologics industry with a new subcutaneous auto-injector.
Any drug therapy is only as good as its weakest link, and for many injectable drugs, the limiting component is the prefilled auto-injector patients use to self-administer their medications.
